Living nano-micro fibrous woven fabric/hydrogel composite scaffolds for heart valve engineering
Source abstract
Abstract
Regeneration and repair of injured or diseased heart valves remains a clinical challenge. Tissue engineering provides a promising treatment approach to facilitate living heart valve repair and regeneration. Three-dimensional (3D) biomimetic scaffolds that possess heterogeneous and anisotropic features that approximate those of native heart valve tissue are beneficial to the successful in vitro development of tissue engineered heart valves (TEHV). Here we report the development and characterization of a novel composite scaffold consisting of nano- and micro-scale fibrous woven fabrics and 3D hydrogels by using textile techniques combined with bioactive hydrogel formation. Embedded nano-micro fibrous scaffolds within hydrogel enhanced mechanical strength and physical structural anisotropy of the composite scaffold (similar to native aortic valve leaflets) and also reduced its compaction. We determined that the composite scaffolds supported the growth of human aortic valve interstitial cells (HAVIC), balanced the remodeling of heart valve ECM against shrinkage, and maintained better physiological fibroblastic phenotype in both normal and diseased HAVIC over single materials. These fabricated composite scaffolds enable the engineering of a living heart valve graft with improved anisotropic structure and tissue biomechanics important for maintaining valve cell phenotypes. Statement of significance Heart valve-related disease is an important clinical problem, with over 300,000 surgical repairs performed annually. Tissue engineering offers a promising strategy for heart valve repair and regeneration. In this study, we developed and tissue engineered living nano-micro fibrous woven fabric/hydrogel composite scaffolds by using textile technique combined with bioactive hydrogel formation. The novelty of our technique is that the composite scaffolds can mimic physical structure anisotropy and the mechanical strength of natural aortic valve leaflet. Moreover, the composite scaffolds prevented the matrix shrinkage, which is major problem that causes the failure of TEHV, and better maintained physiological fibroblastic phenotype in both normal and diseased HAVIC. This work marks the first report of a combination composite scaffold using 3D hydrogel enhanced by nano-micro fibrous woven fabric, and represents a promising tissue engineering strategy to treat heart valve injury.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (87)
Show source-provided references
1. Will heart valve tissue engineering change the world10.1038/ncpcardio0112 ↗
2. Bioengineering challenges for heart valve tissue engineering10.1146/annurev-bioeng-061008-124903 ↗
3. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology10.1007/s12265-011-9300-4 ↗
4. Thromboembolic and bleeding complications in patients with mechanical heart-valve prostheses10.1161/01.CIR.89.2.635 ↗
5. Calcification of tissue heart valve substitutes: progress toward understanding and prevention10.1016/j.athoracsur.2004.06.033 ↗
6. Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions10.1517/14712598.2015.1051527 ↗
7. Scaffolds for tissue engineering of cardiac valves10.1016/j.actbio.2014.03.014 ↗
8. Aortic valve disease and treatment: the need for naturally engineered solutions10.1016/j.addr.2011.01.008 ↗
9. How to make a heart valve: from embryonic development to bioengineering of living valve substitutes10.1101/cshperspect.a013912 ↗
10. Form follows function: advances in trilayered structure replication for aortic heart valve tissue engineering10.1260/2040-2295.3.2.179 ↗
11. Tissue-engineered heart valve scaffolds
12. Cell-laden microengineered gelatin methacrylate hydrogels10.1016/j.biomaterials.2010.03.064 ↗
13. Valvulogenesis: the moving target10.1098/rstb.2007.2130 ↗
14. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology10.2353/ajpath.2007.070251 ↗
15. On the biaxial mechanical properties of the layers of the aortic valve leaflet10.1115/1.2768111 ↗
16. Characterizing the collagen fiber orientation in pericardial leaflets under mechanical loading conditions10.1007/s10439-012-0696-z ↗
17. Approaches to heart valve tissue engineering scaffold design10.1002/jbm.b.30763 ↗
18. Biomaterials for vascular tissue engineering10.2217/rme.09.77 ↗
19. Polymeric scaffolds in tissue engineering application: a review10.1155/2011/290602 ↗
20. Early in vivo experience with tissue-engineered trileaflet heart valves10.1161/circ.102.suppl_3.III-22 ↗
21. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen10.1089/ten.a.2007.0148 ↗
22. In vivo monitoring of function of autologous engineered pulmonary valve10.1016/j.jtcvs.2009.11.006 ↗
23. Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function10.1089/ten.tea.2008.0545 ↗
24. Valvular interstitial cell seeded poly (glycerol sebacate) scaffolds: toward a biomimetic in vitro model for heart valve tissue engineering10.1016/j.actbio.2013.01.001 ↗
25. Prediction of extracellular matrix stiffness in engineered heart valve tissues based on nonwoven scaffolds10.1007/s10237-007-0102-1 ↗
26. Laser microfabricated poly (glycerol sebacate) scaffolds for heart valve tissue engineering10.1002/jbm.a.34305 ↗
27. Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation10.1002/jbm.a.34162 ↗
28. A novel composite scaffold for cardiac tissue engineering10.1290/0411071.1 ↗
29. Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves10.1016/j.actbio.2011.02.018 ↗
30. Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels10.1016/j.actbio.2013.04.050 ↗
31. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells10.1016/j.actbio.2013.12.005 ↗
32. Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform10.1002/adhm.201400029 ↗
33. Comparison of mesenchymal stem cell source differentiation toward human pediatric aortic valve interstitial cells within 3D engineered matrices10.1089/ten.tec.2014.0589 ↗
34. Fabrication of aligned nanofiber polymer yarn networks for anisotropic soft tissue scaffolds10.1021/acsami.6b05199 ↗
35. Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration10.1089/ten.teb.2008.0652 ↗
36. Microfluidic chip-based fabrication of PLGA microfiber scaffolds for tissue engineering10.1021/la800253b ↗
37. Controlled cellular orientation on PLGA microfibers with defined diameters10.1007/s10544-009-9287-7 ↗
38. Hybrid PGS–PCL microfibrous scaffolds with improved mechanical and biological properties10.1002/term.313 ↗
39. Uniaxially aligned polyacrylonitrile nanofiber yarns prepared by a novel modified electrospinning method10.1016/j.matlet.2013.05.010 ↗
40. Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells10.1161/ATVBAHA.112.300504 ↗
41. Strain magnitude-dependent calcific marker expression in valvular and vascular cells10.1159/000347007 ↗
42. Tri-layered elastomeric scaffolds for engineering heart valve leaflets10.1016/j.biomaterials.2014.04.039 ↗
43. Anisotropic poly(ethylene glycol)/polycaprolactone hydrogel-fiber composites for heart valve tissue engineering10.1089/ten.tea.2013.0397 ↗
44. Aortic valve mechanics-part I: material properties of natural porcine aortic valves
45. The mechanical properties of porcine aortic valve tissues10.1016/0021-9290(83)90016-7 ↗
46. Biomechanical properties of native and tissue engineered heart valve constructs10.1016/j.jbiomech.2013.09.023 ↗
47. Engineering of a bio-functionalized hybrid off-the-shelf heart valve10.1016/j.biomaterials.2013.10.080 ↗
48. ECM and ECM-like materials – biomaterials for applications in regenerative medicine and cancer therapy10.1016/j.addr.2015.11.019 ↗
49. Fibrous scaffolds for building hearts and heart parts10.1016/j.addr.2015.11.020 ↗
50. Generation and assessment of functional biomaterial scaffolds for applications in cardiovascular tissue engineering and regenerative medicine10.1002/adhm.201400762 ↗
51. A review of: application of synthetic scaffold in tissue engineering heart valves10.1016/j.msec.2014.12.016 ↗
52. Fiber-reinforced hydrogel scaffolds for heart valve tissue engineering10.1177/0885328214530589 ↗
53. Integrating valve-inspired design features into poly(ethylene glycol) hydrogel scaffolds for heart valve tissue engineering10.1016/j.actbio.2014.11.042 ↗
54. Fiber-reinforced scaffolds for tissue engineering and regenerative medicine: use of traditional textile substrates to nanofibrous arrays10.1039/c0jm01443e ↗
55. Fiber-based tissue engineering: progress, challenges, and opportunities10.1016/j.biotechadv.2012.11.007 ↗
56. Radiotherapeutic bandage based on electrospun polyacrylonitrile containing holmium-166 iron garnet nanoparticles for the treatment of skin cancer10.1021/am506045k ↗
57. A nanopatterned cell-seeded cardiac patch prevents electro-uncoupling and improves the therapeutic efficacy of cardiac repair10.1039/c3bm60289c ↗
58. Multi-scale mechanical characterization of scaffolds for heart valve tissue engineering10.1016/j.jbiomech.2012.07.037 ↗
59. Emerging trends in heart valve engineering: part I. Solutions for future10.1007/s10439-014-1209-z ↗
60. Comparison of biomechanical and structural properties between human aortic and pulmonary valve10.1016/j.ejcts.2004.05.043 ↗
61. Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation10.1002/jbm.a.34162 ↗
62. A tough biodegradable elastomer10.1038/nbt0602-602 ↗
63. Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering10.1002/jbm.b.31862 ↗
64. Fiber alignment and coculture with fibroblasts improves the differentiated phenotype of murine embryonic stem cell-derived cardiomyocytes for cardiac tissue engineering10.1002/bit.23353 ↗
65. Electrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropy10.1002/adhm.201300505 ↗
66. Anisotropic strain transfer through the aortic valve and its relevance to the cellular mechanical environment10.1177/0954411911406340 ↗
67. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis10.1152/ajpheart.00521.2005 ↗
68. Modeling the impact of scaffold architecture and mechanical loading on collagen turnover in engineered cardiovascular tissues10.1007/s10237-014-0625-1 ↗
69. Heart valve structure and function in development and disease10.1146/annurev-physiol-012110-142145 ↗
70. 3D structural patterns in scalable, elastomeric scaffolds guide engineered tissue architecture10.1002/adma.201301016 ↗
71. The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs10.1016/j.biomaterials.2010.11.032 ↗
72. Valvular interstitial cell seeded poly(glycerol sebacate) scaffolds: toward a biomimetic in vitro model for heart valve tissue engineering10.1016/j.actbio.2013.01.001 ↗
73. Assessment of mitral valve disease: a review of imaging modalities10.1007/s11936-015-0390-1 ↗
74. Revisiting cardiovascular calcification: a multifaceted disease requiring a multidisciplinary approach10.1016/j.semcdb.2015.09.004 ↗
75. Differential proteoglycan and hyaluronan distribution in calcified aortic valves10.1016/j.carpath.2010.10.002 ↗
76. Statin treatment of hypercholesterolemic-induced aortic valve sclerosis10.1016/j.carpath.2010.01.004 ↗
77. The cardiac valve interstitial cell10.1016/S1357-2725(02)00100-0 ↗
78. Evolving concepts of cardiac valve dynamics the continuum of development, functional structure, pathobiology, and tissue engineering10.1161/CIRCULATIONAHA.108.805911 ↗
79. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves10.1161/hc4601.099489 ↗
80. Valvular myofibroblast activation by transforming growth factor-beta-implications for pathological extracellular matrix remodeling in heart valve disease10.1161/01.RES.0000136520.07995.aa ↗
81. In situ elasticity modulation with dynamic substrates to direct cell phenotype10.1016/j.biomaterials.2009.09.025 ↗
82. Bone formation and inflammation in cardiac valves10.1161/01.CIR.103.11.1522 ↗
83. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity
84. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography10.1161/01.CIR.0000135469.82545.D0 ↗
85. Aortic valve stenosis10.1016/j.anclin.2009.07.012 ↗
86. Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease10.1161/ATVBAHA.110.211029 ↗
87. Biophysical analysis of dystrophic and osteogenic models of valvular calcification10.1115/1.4029115 ↗